Search - tctmd.com

Displaying 741 - 760 of 1475

Sort: Relevancy | Date

Presentation TCT 2016

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, David J. Cohen

November 01, 2016

Presentation TCT 2016

Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? No - So Many Questions Are Still Unanswered!

Presenter: Robert A. Guyton, Martin B. Leon, Marc Ruel

October 31, 2016

Presentation TCT 2016

Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? Yes the Issue Is No Longer in Doubt!

Presenter: Robert A. Guyton, Martin B. Leon, David E. Kandzari

October 31, 2016

Presentation TCT 2016

OCT-guided vs Angio-guided Left Main Treatment: Rationale and Design of the OCTOBER Trial

Presenter: Evald H. Christiansen, Per Hostrup Nielsen, Niels R. Holm

October 31, 2016

Presentation TCT 2016

SYNTAX Stratified NOBLE Results

Presenter: Evald H. Christiansen, Per Hostrup Nielsen, Ian Menown

October 31, 2016

Presentation TCT 2016

NOBLE Left main Bifurcation Stent Techniques

Presenter: Evald H. Christiansen, Per Hostrup Nielsen, Mitchell Lindsay

October 31, 2016

Presentation TCT 2016

Diabetes in the NOBLE Trial

Presenter: Evald H. Christiansen, Per Hostrup Nielsen, Olli A. Kajander

October 31, 2016

Presentation TCT 2016

NOBLE Top Line Results Revisited

Presenter: Evald H. Christiansen, Per Hostrup Nielsen

October 31, 2016

Presentation TCT 2016

IVUS-guided Left Main and Non-left Main Stenting in the EXCEL Trial: Lessons From the EXCEL IVUS Core Laboratory

Presenter: A. Pieter Kappetein, Marie-Claude Morice, Akiko Maehara

October 31, 2016

Presentation TCT 2016

Rationale and Principal Results of the Excel Trial

Presenter: Alejandro Cherro, Anibal A. Damonte, Alfredo E. Rodriguez, Tullio Palmerini

October 31, 2016

Presentation TCT 2016

EXCEL Outcomes in Patients With and Without Chronic Kidney Disease

Presenter: A. Pieter Kappetein, Marie-Claude Morice, Joseph F. Sabik

October 31, 2016

Presentation TCT 2016

EXCEL Outcomes in Men and Women

Presenter: A. Pieter Kappetein, Marie-Claude Morice, Patrick W. Serruys

October 31, 2016

Presentation TCT 2016

EXCEL Outcomes in Diabetic and Non-diabetic Patients

Presenter: A. Pieter Kappetein, Marie-Claude Morice

October 31, 2016

Presentation TCT 2016

Site-reported vs Core Lab Syntax Scores: Discordance and Impact on Outcomes After PCI vs CABG in EXCEL

Presenter: A. Pieter Kappetein, Marie-Claude Morice, Philippe Généreux

October 31, 2016

Presentation TCT 2016

EXCEL Top Line Results Revisited

Presenter: A. Pieter Kappetein, Marie-Claude Morice, Gregg W. Stone

October 31, 2016

Presentation TCT 2016

Impact of Operator Experience on Left Main PCI Outcomes: Fu Wai Experience

Presenter: Seung-Jung Park, Leif Thuesen, Bo Xu

October 31, 2016

Presentation TCT 2016

Making Sense: From Risk Scores to Triage Left Main Patients to PCI vs CABG

Presenter: Seung-Jung Park, Leif Thuesen, Davide Capodanno

October 31, 2016

Presentation TCT 2016

Pre-EXCEL and NOBLE: What Have We Learned From Contemporary Left Main Randomized Trials?

Presenter: Seung-Jung Park, Leif Thuesen, Marie-Claude Morice

October 31, 2016

Presentation TCT 2016

Early Insights From the DELTA-2 Registry

Presenter: Seung-Jung Park, Leif Thuesen, Alaide Chieffo

October 31, 2016

Presentation TCT 2016

What Have We Learned From Contemporary Left Main Observational Studies IV? FLORENCE-LM Registry

Presenter: Seung-Jung Park, Leif Thuesen, David Antoniucci (RETIRED)

October 31, 2016

Advertisement

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? No - So Many Questions Are Still Unanswered!

Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? Yes the Issue Is No Longer in Doubt!

OCT-guided vs Angio-guided Left Main Treatment: Rationale and Design of the OCTOBER Trial

SYNTAX Stratified NOBLE Results

NOBLE Left main Bifurcation Stent Techniques

Diabetes in the NOBLE Trial

NOBLE Top Line Results Revisited

IVUS-guided Left Main and Non-left Main Stenting in the EXCEL Trial: Lessons From the EXCEL IVUS Core Laboratory

Rationale and Principal Results of the Excel Trial

EXCEL Outcomes in Patients With and Without Chronic Kidney Disease

EXCEL Outcomes in Men and Women

EXCEL Outcomes in Diabetic and Non-diabetic Patients

Site-reported vs Core Lab Syntax Scores: Discordance and Impact on Outcomes After PCI vs CABG in EXCEL

EXCEL Top Line Results Revisited

Impact of Operator Experience on Left Main PCI Outcomes: Fu Wai Experience

Making Sense: From Risk Scores to Triage Left Main Patients to PCI vs CABG

Pre-EXCEL and NOBLE: What Have We Learned From Contemporary Left Main Randomized Trials?

Early Insights From the DELTA-2 Registry

What Have We Learned From Contemporary Left Main Observational Studies IV? FLORENCE-LM Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content